Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Orthofix To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Orthofix between October 11, 2022, and September 12, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Aug. 29, 2024 (G ...

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Aug. 29, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Orthofix Medical Inc. ("Orthofix Medical" or the "Company") (NASDAQ: OFIX) investors of a class action representing investors that bought securities between October 11, 2022 and September 12, 2023, inclusive (the "Class Period"). Orthofix Medical investors have until October 21, 2024 to file a lead plaintiff motion. Investors are encouraged to ...

LOS ANGELES , Aug. 29, 2024 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Orthofix Medical Inc. ("Orthofix" or the "Company") (NASDAQ: OFIX). Class Period: October 11, 2022 – September 12, 2023 Lead Plaintiff Deadline: October 21, 2024 If you are a shareholder who suffered a loss, click here to participate. The complaint filed alleges that, throughout the Class Period, Defendants fa ...

NEW ORLEANS, Aug. 28, 2024 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 21, 2024 to file lead plaintiff applications in a securities class action lawsuit against Orthofix Medical, Inc. (NasdaqGS: OFIX), if they purchased the Company's shares between October 11, 2022, and September 12, 2023, inclusive (the "Class Period"). This action is pending in the United States District Court for the Eastern District of Texas. Get Help Orthofix i ...

LOS ANGELES, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming October 21, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Orthofix Medical Inc. ("Orthofix" or the "Company") (NASDAQ: OFIX) common stock between October 11, 2022 and September 12, 2023, inclusive (the "Class Period"). If you suffered a loss on your Orthofix investments or would like to inquire about potentia ...

NEW ORLEANS, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until October 21, 2024 to file lead plaintiff applications in a securities class action lawsuit against Orthofix Medical, Inc. (NasdaqGS: OFIX), if they purchased the Company's shares between October 11, 2022, and September 12, 2023, inclusive (the "Class Period"). This action is pending in the United States District Court ...

NEW YORK, Aug. 27, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Orthofix Medical Inc. (NASDAQ: OFIX) between October 11, 2022 and September 12, 2023, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 21, 2024. So what: If you purchased Orthofix common stock during ...

PHILADELPHIA, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Nationally recognized law firm Berger Montague PC informs investors that a lawsuit was filed against Orthofix Medical, Inc. ("Orthofix" or the "Company") (NASDAQ: OFIX) on behalf of purchasers of Orthofix securities between October 11, 2022 and September 12, 2023, inclusive (the "Class Period"). Investors that suffered losses from Orthofix (NASDAQ: OFIX) investments can follow the link below for more information regarding the lawsuit: CLICK HERE to learn more ...

PHILADELPHIA, Aug. 26, 2024 (GLOBE NEWSWIRE) -- A securities fraud lawsuit has been filed against Orthofix Medical, Inc. ("Orthofix" or the "Company") (NASDAQ: OFIX). The lawsuit is captioned Bernal v. Orthofix Medical, Inc., No. 2:24-cv-00690 (E.D. Tex.), and is filed on behalf of purchasers of Orthofix securities between October 11, 2022 and September 12, 2023, inclusive (the "Class Period"). CLICK HERE TO LEARN MORE ABOUT THIS LAWSUIT. Investors who purchased or acquired Orthofix securities during the Cl ...

Class Action Lawsuit - A class action lawsuit has been filed against Orthofix Medical Inc (NASDAQ: OFIX) alleging securities fraud or other unlawful business practices by the company and certain officers/directors [1][2] - Shareholders who purchased Orthofix securities during the Class Period have until October 21, 2024 to request appointment as Lead Plaintiff [2] Executive Changes - On September 12, 2023, Orthofix announced the immediate appointment of interim CEO, CFO, and Chief Legal Officer following the termination of Keith Valentine, John Bostjancic and Patrick Keran from those roles [2] - The terminations resulted from an investigation that found the executives engaged in repeated inappropriate and offensive conduct violating the company's code of conduct and values [2] Stock Price Impact - Orthofix's stock price fell $5 62 per share or 30 17% to close at $13 01 per share on September 12, 2023 following the executive changes announcement [2] Law Firm Background - Pomerantz LLP, the law firm handling the class action, is a premier firm in corporate, securities and antitrust class litigation with offices in New York, Chicago, Los Angeles, London, Paris and Tel Aviv [3] - Founded over 85 years ago, Pomerantz has recovered billions of dollars in damages for class members in securities fraud and corporate misconduct cases [3]